A61K 2039/53
Dna vaccination
Official title: {DNA (RNA) vaccination}
A61K2039/53 (Dna vaccination) appears on 3,535 US grants and 6,543 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,535
- Published applications
- 6,543
- Assignees
- 1,977
- Inventors
- 9,293
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 13 | 0 |
| 1998 | 21 | 0 |
| 1999 | 22 | 0 |
| 2000 | 32 | 0 |
| 2001 | 57 | 19 |
| 2002 | 66 | 198 |
| 2003 | 71 | 273 |
| 2004 | 92 | 325 |
| 2005 | 82 | 267 |
| 2006 | 110 | 235 |
| 2007 | 120 | 258 |
| 2008 | 136 | 232 |
| 2009 | 140 | 246 |
| 2010 | 156 | 264 |
| 2011 | 164 | 247 |
| 2012 | 152 | 230 |
| 2013 | 129 | 177 |
| 2014 | 148 | 172 |
| 2015 | 133 | 193 |
| 2016 | 143 | 245 |
| 2017 | 148 | 220 |
| 2018 | 169 | 200 |
| 2019 | 159 | 260 |
| 2020 | 140 | 202 |
| 2021 | 154 | 238 |
| 2022 | 159 | 319 |
| 2023 | 176 | 367 |
| 2024 | 155 | 455 |
| 2025 | 170 | 365 |
| 2026 | 106 | 336 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lipid nanoparticles comprising sterols and mRNA6 Oct 2026US 12,751,999 B2eTheRNA Immunitherapies NV
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Long-acting low-toxicity novel cationic lipid compounds and composition thereof29 Sep 2026US 12,746,208 B2Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- Ambient temperature lipid particle storage systems and methods29 Sep 2026US 12,746,281 B2Ambient Biosciences, Inc.
- Selection of cancer mutations for generation of a personalized cancer vaccine29 Sep 2026US 12,749,556 B2Nouscom AG
- Modular multiplatform system for mrna drug production8 Oct 2026US 2026/0306407 A1BioNTech SE
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Antigen-specific physiologic dendritic cells for therapy8 Oct 2026US 2026/0306597 A1Emory University
- Sarcoma cancer vaccines and uses thereof8 Oct 2026US 2026/0306600 A1
- Lipid nanoparticles for the prevention of tuberculosis or other mycobacterial infections8 Oct 2026US 2026/0306603 A1Akagera Medicines, Inc.
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant395US 6,406,705 B1Coley Pharmaceutical GmbH · 2002
- Vectors and methods for immunization or therapeutic protocols285US 6,339,068 B12002
- Genetic immunization277US 5,593,972 AThe Trustees of the University of Pennsylvania · 1997
- Application of mRNA for use as a therapeutic agent for tumorous diseases194US 8,217,016 B2CureVac AG · 2012